Cellectis SA engages as a biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells. It offers Gene editing and Immuno-oncology. The company was founded by David J. Sourdive and AndrÃ© Choulika on February 20, 1999 and is headquartered in Paris, France.
Need a custom stock scraper? Want to do some machine learning? We are here to help! Reach out to us!